Skip to content

Effect of androgen deprivation therapy on bladder cancer recurrence.

Effect of androgen deprivation therapy on bladder cancer recurrence. - Effect of androgen deprivation therapy on bladder cancer recurrence.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000012926
Enrollment
200
Registered
2014-01-23
Start date
2014-01-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer and prostate cancer

Interventions

None listed

Sponsors

Yokohama Cancer of Prostate Group
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients with double primary cancer of bladder and prostate cancer.

Exclusion criteria

Exclusion criteria: Bladder cancer except for urothelial cancer.

Design outcomes

Primary

MeasureTime frame
Recurrence free survival Cumulative recurrence

Countries

Japan

Contacts

Public ContactHiroji Uemura

Yokohama City University Hospital Urology

hu0428@med.yokohama-cu.ac.jp045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026